COATED DRUG SPHEROIDS AND USES THEREOF FOR ELIMINATING OR REDUCING CONDITIONS SUCH AS EMESIS AND DIARRHEA
The present invention provides an oral pharmaceutical formulation comprising coated spheroids of a kinase inhibitor such as neratinib, which formulation is designed to reduce or eliminate side effects associated with existing oral formulations of kinase inhibitors.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
03.04.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides an oral pharmaceutical formulation comprising coated spheroids of a kinase inhibitor such as neratinib, which formulation is designed to reduce or eliminate side effects associated with existing oral formulations of kinase inhibitors. |
---|---|
Bibliography: | Application Number: EP20100787212 |